Ionis Pharmaceuticals (IONS) insider trading in the last 6 months

One insider bought $1.1M, 2 sold $61K.

Quality Score-8Poor

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 4 tradesSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Form 4 filings, newest first

SellShannon L. Devers$59KEVP, Chief Human Resources Ofcat $43.54 on Oct 16, filed Oct 19

SellShannon L. DeversEVP, Chief Human Resources Ofc$59Kat $43.54 on Oct 16, filed Oct 19

SellEric Swayze$2KEVP Researchat $43.54 on Oct 16, filed Oct 19

SellEric SwayzeEVP Research$2Kat $43.54 on Oct 16, filed Oct 19

BuyMichael R. Hayden$801KDirectorat $53.38 on Jul 30, filed Jul 31

BuyMichael R. HaydenDirector$801Kat $53.38 on Jul 30, filed Jul 31

From SEC Form 4s, the newest filed Oct 19, 2026 · Insiders have 2 business days to file a trade

Pro members see every filing on IONS with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Ionis Pharmaceuticals

Insider trades by person

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about IONS's insider trades

As of Nov 10, 2026: Ionis Pharmaceuticals (IONS) has 4 insider filings on record in the last 6 months, the newest filed Oct 19, 2026. Its Quality Score is -8 (Poor). Scores as of 10:56 PM ET, 15 minutes behind.

Are IONS insiders buying or selling?

One insider bought $1.1M across 2 filings, and 2 insiders sold $61K across 2 filings, in the last 6 months. The newest filing: Shannon L. Devers, EVP, Chief Human Resources Ofc, sold $59K on Oct 16, 2026.

Who are IONS's biggest insider sellers?

By the dollars of their sales in the last 6 months: Shannon L. Devers (EVP, Chief Human Resources Ofc), 1 sale; Eric Swayze (EVP Research), 1 sale.

When did an IONS insider last buy?

Michael R. Hayden, Director, bought IONS shares ($801K) on Jul 30, 2026, filed Jul 31, 2026, the newest insider buy on record.

Ionis Pharmaceuticals's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.

Ionis Pharmaceuticals (IONS) insider trading in the last 6 months

Form 4 filings, newest first

Who files at Ionis Pharmaceuticals

Questions about IONS's insider trades

Every insider trade, with its stock's score.